Cargando…
Giant retroperitoneal leiomyosarcoma. Multiorgan block removal
INTRODUCTION: Retroperitoneal tumors are rare, mostly malignant. Locally aggressive, and more frequent in women in their 5th decade of life. Its symptoms are nonspecific, including abdominal pain and palpable mass. To diagnosis is helpful computed tomography and biopsy. It needs surgery for absolute...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275809/ https://www.ncbi.nlm.nih.gov/pubmed/25460472 http://dx.doi.org/10.1016/j.ijscr.2014.10.061 |
_version_ | 1782350180743380992 |
---|---|
author | Mateo Vallejo, F. Dominguez Reinado, M.R. Medina Achirica, C. Diaz Oteros, M. Esteban Ramos, J.L. Melero Brenes, S. |
author_facet | Mateo Vallejo, F. Dominguez Reinado, M.R. Medina Achirica, C. Diaz Oteros, M. Esteban Ramos, J.L. Melero Brenes, S. |
author_sort | Mateo Vallejo, F. |
collection | PubMed |
description | INTRODUCTION: Retroperitoneal tumors are rare, mostly malignant. Locally aggressive, and more frequent in women in their 5th decade of life. Its symptoms are nonspecific, including abdominal pain and palpable mass. To diagnosis is helpful computed tomography and biopsy. It needs surgery for absolute healing. PRESENTATION OF CASE: 67 years old man was admitted with back pain and fever. Abdominal imaging tests showed a 15 cm abdominal mass without clear organodependencia. Endoscopy with biopsies evidenced mesenchymal neoplasia of undetermined origin. In surgery we confirm its resecability and was necessary multiorgan resection. Pathologic diagnosis: well differentiated retroperitoneal leiomyosarcoma. Started adjuvant radiotherapy. In subsequent tests showed the presence of liver metastases. DISCUSSION: Retroperitoneal tumors are developed from nerve, vascular, muscular, connective, supportive and fibroareolar tissue from this space. Its size does not modificate survival or resectability. We used TC and biopsy for its diagnose. Adjuvant therapy does not affect survival or quality of life, surgery remains the only curative option. Locoregional recurrence is the most influential figure in the prognosis. A large percentage of patients required a second surgery (between 45 and 82%). CONCLUSION: The only curative option of retroperitoneal sarcomas is surgery, which usually requires multiple organ resection. Chemotherapy and radiotherapy are mostly a surgical supplement. Chemotherapy has not shown significant increase in survival. |
format | Online Article Text |
id | pubmed-4275809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-42758092014-12-28 Giant retroperitoneal leiomyosarcoma. Multiorgan block removal Mateo Vallejo, F. Dominguez Reinado, M.R. Medina Achirica, C. Diaz Oteros, M. Esteban Ramos, J.L. Melero Brenes, S. Int J Surg Case Rep Article INTRODUCTION: Retroperitoneal tumors are rare, mostly malignant. Locally aggressive, and more frequent in women in their 5th decade of life. Its symptoms are nonspecific, including abdominal pain and palpable mass. To diagnosis is helpful computed tomography and biopsy. It needs surgery for absolute healing. PRESENTATION OF CASE: 67 years old man was admitted with back pain and fever. Abdominal imaging tests showed a 15 cm abdominal mass without clear organodependencia. Endoscopy with biopsies evidenced mesenchymal neoplasia of undetermined origin. In surgery we confirm its resecability and was necessary multiorgan resection. Pathologic diagnosis: well differentiated retroperitoneal leiomyosarcoma. Started adjuvant radiotherapy. In subsequent tests showed the presence of liver metastases. DISCUSSION: Retroperitoneal tumors are developed from nerve, vascular, muscular, connective, supportive and fibroareolar tissue from this space. Its size does not modificate survival or resectability. We used TC and biopsy for its diagnose. Adjuvant therapy does not affect survival or quality of life, surgery remains the only curative option. Locoregional recurrence is the most influential figure in the prognosis. A large percentage of patients required a second surgery (between 45 and 82%). CONCLUSION: The only curative option of retroperitoneal sarcomas is surgery, which usually requires multiple organ resection. Chemotherapy and radiotherapy are mostly a surgical supplement. Chemotherapy has not shown significant increase in survival. Elsevier 2014-10-31 /pmc/articles/PMC4275809/ /pubmed/25460472 http://dx.doi.org/10.1016/j.ijscr.2014.10.061 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
spellingShingle | Article Mateo Vallejo, F. Dominguez Reinado, M.R. Medina Achirica, C. Diaz Oteros, M. Esteban Ramos, J.L. Melero Brenes, S. Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title | Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title_full | Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title_fullStr | Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title_full_unstemmed | Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title_short | Giant retroperitoneal leiomyosarcoma. Multiorgan block removal |
title_sort | giant retroperitoneal leiomyosarcoma. multiorgan block removal |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275809/ https://www.ncbi.nlm.nih.gov/pubmed/25460472 http://dx.doi.org/10.1016/j.ijscr.2014.10.061 |
work_keys_str_mv | AT mateovallejof giantretroperitonealleiomyosarcomamultiorganblockremoval AT dominguezreinadomr giantretroperitonealleiomyosarcomamultiorganblockremoval AT medinaachiricac giantretroperitonealleiomyosarcomamultiorganblockremoval AT diazoterosm giantretroperitonealleiomyosarcomamultiorganblockremoval AT estebanramosjl giantretroperitonealleiomyosarcomamultiorganblockremoval AT melerobreness giantretroperitonealleiomyosarcomamultiorganblockremoval |